Skip to main content

Table 2 Inclusion and exclusion criteria

From: Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19): a structured summary of a study protocol for a randomized controlled trial

Inclusion criteria Exclusion criteria
1. Over 18 years of age who reside in the province of Corrientes at the time of diagnosis 1. Pregnant or breastfeeding women
2.Confirmed diagnosis of COVID-19 by polymerase chain reaction test for detection of SARS-CoV2 in the last 48 h 2. Known allergy to ivermectin or some of the components of ivermectin tablets or placebo
3. In case of being women of childbearing age, they must be using a contraceptive method of proven efficacy and safety (barrier, hormonal, or permanent contraceptives) for at least 3 months prior to inclusion in the present study, during the entire period of time for the duration of the study, and until at least 30 days after the end of this study. A woman will be considered to have no reproductive capacity if she is postmenopausal (at least 2 years without her menstrual cycles) or if she has undergone surgical sterilization (at least 1 month before the time of inviting her to participate in this study) 3. Current use of home oxygen
4. Weight at the time of inclusion equal to or greater than 48 kg 4. That require hospitalization due to COVID-19 at the time of diagnosis or history of hospitalization for COVID-19
5. That they sign the informed consent for participation in the study 5. Presence of mal-absorptive syndrome
  6. Presence of any other concomitant acute infectious disease
  7. Known history of severe liver disease, for example liver cirrhosis
  8. Need or use of antiviral drugs at the time of admission for another viral pathology other than COVID-19
  9. Need or use of hydroxychloroquine or chloroquine
  10. Use of ivermectin up to 7 days prior to randomization
  11. Patients on dialysis or who have required it in the last 2 months or who plan to do it in the next 2 months
  12. Current participation or in the last 30 days in a research study that has included the administration of a drug